Drawing for AMERICAN PHARMACEUTICALS

USPTO serial 85057059

AMERICAN PHARMACEUTICALS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LEASER, ANDREW C
Law office
TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AMERICAN PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Generic and proprietary injectable prescription pharmaceuticals, namely, alkalinizing agents for treating Antacid and acid reflux disease, analgesics and anesthetics for surgical use, general anesthetics, topical anesthetics, anticholinergics, anti-infectives, anti-inflammatory agents, antipsychotics, blood modifiers, cardiovascular medications, electrolytes, Oral rehydration solutions (ORS) encaplislated salts for rehydration solution. vitamins and oncology medications; full line of pharmaceutical preparations; prescription, generic and over the counter pharmaceutical preparations, namely, vitamins, anti-histamines, anti-infective agents, antibiotics, anti-inflamatory drugs, anti-anemia drugs, cardiovascular drugs, central nervous system drugs, namely, analgesics, anticonvulsants, psychotherapeutic agents; pharmaceutical preparations for use in intravenous systems, namely, electrolytic, caloric and water balanced solutions for the treatment of dehydration. Pharmaceutical preparations for the treatment of ear, nose and throat ailments in the form of drops and sprays for treatment of infection, allergy, sinus, eye and ear infections; gastrointestinal drugs and spasmodics, bactericidal preparations, namely, antiseptic cleansing solutions for skin irritation, sanitary sterilizing preparations, namely, solutions for sterilizing and disinfecting for use in laboratories, hospitals, dental, and medical settings, germicidesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 1, 2011MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 1, 2011ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 29, 2010GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 29, 2010GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 29, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 10, 2010DOCKASSIGNED TO EXAMINER—
Sep 28, 2010DMCCDATA MODIFICATION COMPLETED—
Sep 27, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 27, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 27, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2010ALIEASSIGNED TO LIE—
Sep 27, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2010DOCKASSIGNED TO EXAMINER—
Jun 15, 2010MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Jun 14, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 11, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance